Understanding Pericarditis: A Patient's Complete Guide

When a patient comes into my office holding their chest and describing a sharp, stabbing pain that gets worse when they lie down, pericarditis is usually high on my list. It’s inflammation of the thin sac around the heart, and it can be frightening to go through. Most cases respond well to treatment when we catch them early.

I’ve been treating heart conditions in San Diego for years, and pericarditis still creates a lot of anxiety. The chest pain can be intense, and plenty of people walk in convinced they’re having a heart attack. Here’s what the condition actually is, what causes it, and how we treat it, so you can approach your care with some calm instead of fear.

Pericarditis is inflammation of the pericardium, the thin, two-layered sac that wraps around your heart like an envelope. It works as your heart’s shock absorber. When that membrane gets inflamed, it can cause severe chest pain and other symptoms that disrupt your daily life. As scary as it sounds, most cases get better with anti-inflammatory medications.

The thing that sets pericarditis apart from a heart attack is the nature of the pain and how it changes with position. The sharp, stabbing chest pain typically gets worse when you lie flat and eases up when you sit forward and lean toward your knees. That positional pattern is one of the clearest clues I look for when I examine you.

How pericarditis develops and affects your heart

The pericardium has two layers with a small amount of fluid between them, which lets your heart beat smoothly without friction. When inflammation sets in, those layers thicken and roughen, and they start to rub as your heart beats. That friction is what causes the chest pain, and it sometimes produces a sound called a pericardial friction rub that I can hear through my stethoscope.

A lot of the time, especially here in the United States, we never pin down a specific cause. We call that idiopathic pericarditis, and we assume it was triggered by a viral infection your body has already cleared. Your immune system can keep responding to that first trigger, which keeps the inflammation going around your heart.

Pericarditis can also come from bacterial infections, autoimmune diseases like lupus or rheumatoid arthritis, kidney failure, certain cancers, radiation therapy, or chest trauma. Sometimes it shows up after heart surgery or a heart attack, which we call post-cardiac injury syndrome. Each of these can call for a slightly different treatment, which is why working out the underlying cause matters.

The inflammation can also drive up fluid production between the pericardial layers, creating what we call a pericardial effusion. A small amount of fluid is normal, but larger effusions can press on your heart and limit how well it fills with blood. That’s why we watch pericarditis patients closely with echocardiograms and other imaging.

Understanding your test results and diagnosis

When I suspect pericarditis, I look for specific criteria to confirm it. You need at least two of four findings. The characteristic chest pain. A pericardial friction rub on exam. Specific changes on your electrocardiogram (ECG). Or a new or worsening pericardial effusion on imaging.

The ECG changes in pericarditis are fairly distinctive. A heart attack usually shows changes in specific areas of the heart, but pericarditis often causes widespread ST-segment elevation across many leads. You might also see PR-segment depression, another hallmark. Both reflect how broadly the inflammation spreads around your heart.

Blood tests play a supporting role. Elevated inflammatory markers like C-reactive protein (CRP) or erythrocyte sedimentation rate (ESR) point to inflammation somewhere in your body. They aren’t specific to pericarditis and can rise in plenty of other conditions, so I use them more to track your response to treatment than to make the diagnosis.

Echocardiography is one of our most useful tools here. This ultrasound of your heart shows whether there’s fluid around it and how much. We sort pericardial effusions into small (50-100 mL), moderate (100-500 mL), or large (more than 500 mL). What matters more than the raw size is how fast the fluid built up and whether it’s affecting how your heart works.

Advanced imaging like cardiac MRI or CT can tell us more about how thick the pericardium is and what any fluid looks like. These studies earn their keep when we’re trying to find the underlying cause or planning treatment for cases that keep coming back.

Who gets pericarditis and what raises the risk

Pericarditis can hit at any age, but it’s most common in adults between 20 and 50. Men are affected a little more often than women, though the gap is small. If you’re younger when it shows up, it’s more likely to be idiopathic or viral. Older patients more often have pericarditis tied to another medical condition.

Some things push your risk up. An autoimmune disease, kidney failure, or cancer all raise it. A recent viral infection, even something common like the flu or COVID-19, can sometimes trigger pericarditis weeks later. Chest trauma from an accident or a medical procedure can set off pericardial inflammation too.

If you’ve had pericarditis before, you face a 15-30% chance of recurrence, especially if your first episode wasn’t treated with colchicine or you needed corticosteroids. Preventing that next episode is a big part of how we plan treatment. Family history doesn’t seem to count for much with pericarditis, which sets it apart from a lot of other heart conditions.

Your overall health shapes both your risk and your outlook. If you’re otherwise healthy, you’ll most likely have a straightforward course and a full recovery. If you carry several medical conditions or a weakened immune system, we stay more watchful for complications and may adjust your treatment.

Choosing treatment for your specific case

The foundation of pericarditis treatment is anti-inflammatory medication. For most patients I start with high-dose nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen 600-800 mg every 8 hours or aspirin 650-1000 mg three times daily. These handle both the pain and the inflammation driving it.

Colchicine matters just as much. Taken at 0.5-0.6 mg once or twice daily for three months, it cuts your risk of recurrence and helps your current episode clear faster. I adjust the dose for your weight and kidney function. It can cause some stomach upset, but most people tolerate it well, and the benefit far outweighs that.

I always add a proton pump inhibitor like omeprazole alongside high-dose NSAIDs to protect your stomach lining. The anti-inflammatory combination can be rough on your digestive tract, and heading off a stomach problem is far easier than treating one after it starts.

Corticosteroids like prednisone are for specific situations. I’ll consider them if you can’t tolerate NSAIDs and colchicine, if you have severe symptoms that aren’t responding to first-line treatment, or if your pericarditis is tied to an autoimmune condition. Steroids raise your risk of recurrence, so I try to avoid them, and when they’re needed I taper them slowly.

For recurrent pericarditis that won’t respond to standard treatment, we have newer options like IL-1 blockers such as anakinra or rilonacept. These target specific inflammatory pathways and can work well for tough cases. They take careful monitoring and cost a good deal more than traditional treatments.

Common fears and misconceptions

A lot of patients worry that pericarditis means a heart attack or permanent damage to the heart. Pericarditis is painful and unsettling, but it rarely leaves lasting damage to the heart muscle. The inflammation sits in the surrounding membrane, not in the muscle that pumps your blood.

Another common fear is that it’ll keep coming back forever. Recurrence is possible, but proper treatment with colchicine drops that risk a lot. Most patients who finish their treatment plan have no further episodes. Even with recurrences, we have good treatments, and each episode tends to be milder than the first.

Some people assume they’ll have to give up all physical activity for good. That isn’t true for most. During the acute phase I do ask you to avoid strenuous exercise until your symptoms settle and your inflammatory markers come back to normal. Once you’ve recovered, you can usually build back to your normal activity gradually. I work with athletes and active patients regularly to get them safely back to their sports and routines.

Medication side effects also stir up real worry. NSAIDs and colchicine can upset your stomach and cause other side effects, but most people do fine with monitoring and stomach protection. For most patients, the danger of undertreating pericarditis is far greater than the risk from the medications.

What treatment can and can’t do

Our pericarditis treatments work well, but they have limits worth understanding. Anti-inflammatory medications calm the symptoms and the inflammation, yet they don’t always address an underlying cause when there is one. If your pericarditis is secondary to another condition, we treat both the pericarditis and that disease.

Some patients don’t respond to first-line treatment. If you’re in that small group that doesn’t improve on NSAIDs and colchicine, don’t lose hope. We have other options, including different anti-inflammatory medications, immune-suppressing drugs, and in severe cases surgery. Finding the right treatment sometimes takes patience.

Pericardial effusions bring their own challenges. Small ones often clear with anti-inflammatory treatment, but larger ones may need drainage through a procedure called pericardiocentesis, where we insert a needle through the chest wall to remove excess fluid from around your heart. It sounds frightening, and it’s actually quite safe in experienced hands.

Chronic or recurrent pericarditis is harder to treat than a single acute episode. Some patients need long-term anti-inflammatory therapy or immune-suppressing medication. In those cases the goal shifts from cure to steady management and preventing complications, and that takes ongoing teamwork between you and your care team.

When treatment needs to change

There are situations where the standard approach has to be modified or set aside. With severe kidney disease, we adjust doses or pick alternatives, since both NSAIDs and colchicine are processed through your kidneys. An active stomach ulcer or a bleeding disorder calls for special caution with anti-inflammatory therapy.

Pregnancy narrows our options. Many standard pericarditis medications aren’t safe during pregnancy, so we work together to find the safest effective treatment for you and your baby. That often means more frequent monitoring and sometimes accepting a higher level of symptoms to keep medication risk low.

Cardiac tamponade is a medical emergency where the whole approach flips. If pericardial fluid builds up fast and squeezes your heart so it can’t fill properly, we drain the fluid right away. That takes priority over anti-inflammatory treatment, and we’ll usually start medications once the emergency is handled.

When pericarditis comes from a bacterial infection, antibiotics, not anti-inflammatories, become the main treatment. Clearing the infection matters more than reducing inflammation, though we often use both once the infection is under control.

What recovery actually looks like

Recovering from pericarditis usually takes several weeks to a few months, and I want you going in with realistic expectations. Most patients feel better within the first week of treatment, but fully resolving the symptoms and bringing inflammatory markers back to normal often takes longer. Don’t be discouraged if you’re not back to 100% right away.

The chest pain usually improves first, often within the first few days of starting anti-inflammatory medication. You might still feel some discomfort with deep breathing or position changes for several weeks. That gradual improvement is normal and doesn’t mean treatment is failing.

Fatigue is common during recovery, and a lot of patients underestimate it. Your body is fighting inflammation, and the medications can add to the tiredness. Plan for a stretch of lower energy and don’t push too hard too fast. Rest is part of healing.

Follow-up visits and repeat testing are part of the deal. I usually want to see you within a week of starting treatment, then regularly until your symptoms clear and your inflammatory markers normalize. Those visits let me track your progress, adjust medications, and watch for any sign of complications or recurrence.

How pericarditis fits into your overall heart health

Having pericarditis doesn’t mean you have underlying heart disease, and for most patients it doesn’t raise your long-term cardiovascular risk. Once you’ve fully recovered, your heart function should return to normal, and you can keep the same lifestyle and activity level you had before.

That said, pericarditis can be a wake-up call about heart health in general. The experience often nudges patients to pay closer attention to their cardiovascular risk factors like blood pressure, cholesterol, smoking, and exercise. Pericarditis itself isn’t connected to those traditional risk factors, and tightening them up is always worth doing.

If you have recurrent pericarditis, we look at whether there’s an underlying autoimmune or inflammatory condition that needs attention. Sometimes pericarditis is the first sign of a systemic disease that requires its own ongoing management. That doesn’t doom you to poor health, but it does mean we look at the whole picture.

The medications we use for pericarditis can interact with other heart medications if you’re taking those for different conditions. So keep me in the loop about everything you take, and work closely with all your providers so your care stays coordinated.

Where treatment is headed

Pericarditis care keeps moving, with new therapies showing promise for patients who don’t respond well to the standard ones. IL-1 blockers like anakinra and rilonacept have reshaped care for recurrent pericarditis, opening up options for patients who used to have very few.

Research into the genetic and immune basis of recurrent pericarditis is teaching us why some patients have repeated episodes while others have just one. That knowledge may lead to more tailored treatment down the road, where we can spot who’s at risk for recurrence and plan prevention around it.

Imaging keeps getting better at diagnosing and monitoring pericarditis. Cardiac MRI in particular can give detailed information about pericardial inflammation and help guide treatment. As these tools become more available and affordable, they may become a standard part of the workup.

Minimally invasive surgical techniques for recurrent pericarditis and pericardial effusions are improving too. They give patients who don’t respond to medical therapy an alternative, with shorter recovery times and fewer complications than older surgical approaches.

Making informed decisions about your care

A pericarditis diagnosis comes with a few decisions. The first is whether to start the recommended medications despite their possible side effects. I want you asking about the benefits and risks of each option so you can make a choice that fits your values and your situation.

Think about your lifestyle and commitments as we plan. High-dose anti-inflammatory medications can cause drowsiness or stomach upset that may affect your work or daily activities. Planning for that adjustment period helps you stick with your treatment while managing everything else on your plate.

Consider your support system and how pericarditis might touch your family and work life. Some patients need time off during the acute phase, while others keep their usual schedule with a few modifications. Being honest about your limits and needs helps you get the right support during recovery.

Don’t hesitate to get a second opinion if you’re unsure about your diagnosis or your plan. Pericarditis can be tricky to diagnose, and different physicians take different approaches to treatment. Feeling confident in your diagnosis and plan matters for your peace of mind and for following through on therapy.

Using pericarditis treatment well

Pericarditis is frightening the first time you feel it, and it’s a treatable condition with an excellent outlook for most patients. Good outcomes come down to recognizing it early, treating it with anti-inflammatory medications, and following up carefully to prevent recurrence.

The sharp chest pain you’re feeling, as severe as it is, comes from inflammation of the membrane around your heart, not from damage to the heart muscle. With NSAIDs and colchicine, most patients recover completely within weeks to months and go back to their normal lives without restrictions.

Your part in treatment counts. Take your medications as prescribed, even once you start feeling better before the full course is done. Keep your follow-up appointments so we can track your progress and catch any complications early. And call my office if you develop new symptoms or have any concerns about your recovery.

Recurrence is possible, and finishing your complete treatment plan brings that risk down a lot. If episodes do come back, we have effective treatments, and many patients with recurrent pericarditis eventually reach long-term remission with the right therapy. Treatment keeps improving, which gives real hope even for the hardest cases.

References

1. Cremer, Paul C., Allan L. Klein, and Massimo Imazio. “Diagnosis, Risk Stratification, and Treatment of Pericarditis: A Review.” JAMA 332, no. 13 (2024): 1090-1100.

2. LeWinter, Martin M. “Acute Pericarditis.” The New England Journal of Medicine 371, no. 25 (2014): 2410-2416.

3. Klein, Allan L., Suhny Abbara, David A. Agler, et al. “American Society of Echocardiography Clinical Recommendations for Multimodality Cardiovascular Imaging of Patients With Pericardial Disease: Endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography.” Journal of the American Society of Echocardiography 26, no. 9 (2013): 965-1012.

4. Imazio, Massimo, and Yehuda Adler. “Management of Pericardial Effusion.” European Heart Journal 34, no. 16 (2013): 1186-1197.

5. Imazio, Massimo, Fiorenzo Gaita, and Martin LeWinter. “Evaluation and Treatment of Pericarditis: A Systematic Review.” JAMA 314, no. 14 (2015): 1498-1506.

6. Kumar, Sidharth, Sahil Khubber, Rami Reyaldeen, et al. “Advances in Imaging and Targeted Therapies for Recurrent Pericarditis: A Review.” JAMA Cardiology 7, no. 9 (2022): 975-985.

7. Adler, Yehuda, Philippe Charron, Massimo Imazio, et al. “2015 ESC Guidelines for the Diagnosis and Management of Pericardial Diseases.” European Heart Journal 36, no. 42 (2015): 2921-2964.

8. Imazio, Massimo, Antonio Brucato, Silvia Maestroni, et al. “Risk of Constrictive Pericarditis After Acute Pericarditis.” Circulation 124, no. 11 (2011): 1270-1275.

9. Klein, Allan L., Jae K. Oh, William D. Miller, et al. “Two-Dimensional and Doppler Echocardiographic Assessment of Pericardial Disease.” Journal of the American Society of Echocardiography 1, no. 6 (1988): 425-444.

10. Brucato, Antonio, Silvia Maestroni, Gianfranco Parati, et al. “Recent Developments in the Diagnosis and Treatment of Pericardial Diseases.” Current Cardiology Reports 12, no. 6 (2010): 493-501.